India's Zydus begins human trials for potential COVID-19 vaccine
In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India.
Full Article
India's Zydus begins human trials for potential COVID-19 vaccine
Hindu
0 shares
1 views
You might like
Related news coverage
India’s First COVID-19 Vaccine Could Meet Mid-August Target
Eurasia Review
India has set an ambitious timeline for its first potential coronavirus vaccine -- from human trials to general use in six..
-
India readies five sites for final phase of human trials of Oxford COVID vaccine
Mid-Day
-
India's Zydus begins human trials for potential Covid-19 vaccine
IndiaTimes
-
India's Zydus begins human trials for vaccine
IndiaTimes
-
COVID-19 vaccine: Scientists strike note of caution as 'Made in India' vaccine programme gains momentum
Mid-Day
Advertisement
More coverage
India approves human trials for second COVID-19 vaccine candidate
WorldNews
BENGALURU - Zydus has received approval from Indian regulators to begin human studies for its COVID-19 vaccine contender, the..
-
News24.com | India approves human trials for second Covid-19 vaccine candidate
News24
-
Potential COVID-19 vaccine by Zydus Cadila gets DCGI nod for human clinical trials
Hindu
-
Covid-19 vaccine by Ahmedabad-based Zydus Cadila gets DCGI nod for human clinical trials
IndiaTimes
-
Covid vaccine: Ahmd co gets nod for human trials
IndiaTimes